Literature DB >> 32676896

Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy.

Mingfeng Lee1, Hitoshi Suzuki1, Rina Kato1, Yusuke Fukao1, Maiko Nakayama1, Toshiki Kano1, Yuko Makita1, Yusuke Suzuki2.   

Abstract

In several cases with IgA nephropathy (IgAN), differential diagnosis is difficult due to the complication with other systemic diseases which can induce secondary IgAN. Recently, we demonstrated that immunostaining with galactose-deficient IgA1-specific monoclonal antibody (KM55 mAb) specifically showed positive in primary IgAN cases. Here, we report four cases which we could make definitive diagnosis by immunohistological analysis using KM55 mAb. The underlying systemic diseases are rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), hepatitis C (HCV) and Crohn's disease (CD). Renal pathological findings in the four cases revealed mesangial proliferative glomerulonephritis with IgA and C3 deposits. Immunostaining with KM55 mAb was positive for three cases complicated with RA, SLE and CD, respectively. Thus, these three cases were diagnosed as primary IgAN and treated with tonsillectomy and steroid pulse therapy. These three cases finally achieved clinical remission. On the other hand, the case with HCV showed negative for KM55. Finally, we diagnosed as HCV-related nephropathy and successfully treated by antiviral agents. These cases suggested KM55 mAb is a strong tool to differentiate primary IgAN from secondary IgAN.

Entities:  

Keywords:  Galactose-deficient IgA1; IgA deposition; IgA nephropathy; KM55

Year:  2020        PMID: 32676896      PMCID: PMC7829275          DOI: 10.1007/s13730-020-00508-3

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  12 in total

Review 1.  Secondary IgA nephropathy.

Authors:  Manish K Saha; Bruce A Julian; Jan Novak; Dana V Rizk
Journal:  Kidney Int       Date:  2018-05-24       Impact factor: 10.612

Review 2.  Glycosylation of IgA1 and pathogenesis of IgA nephropathy.

Authors:  Jan Novak; Bruce A Julian; Jiri Mestecky; Matthew B Renfrow
Journal:  Semin Immunopathol       Date:  2012-03-21       Impact factor: 9.623

Review 3.  Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.

Authors:  Jan Novak; Zina Moldoveanu; Bruce A Julian; Milan Raska; Robert J Wyatt; Yusuke Suzuki; Yasuhiko Tomino; Ali G Gharavi; Jiri Mestecky; Hitoshi Suzuki
Journal:  Adv Otorhinolaryngol       Date:  2011-08-18

4.  IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.

Authors:  Hitoshi Suzuki; Junichi Yasutake; Yuko Makita; Yuki Tanbo; Kohei Yamasaki; Tadashi Sofue; Toshiki Kano; Yusuke Suzuki
Journal:  Kidney Int       Date:  2018-01-10       Impact factor: 10.612

5.  Proposal of remission criteria for IgA nephropathy.

Authors:  Yusuke Suzuki; Keiichi Matsuzaki; Hitoshi Suzuki; Naoko Sakamoto; Kensuke Joh; Tetsuya Kawamura; Yasuhiko Tomino; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2013-08-04       Impact factor: 2.801

6.  Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.

Authors:  Hitoshi Suzuki; Milan Raska; Koshi Yamada; Zina Moldoveanu; Bruce A Julian; Robert J Wyatt; Yasuhiko Tomino; Ali G Gharavi; Jan Novak
Journal:  J Biol Chem       Date:  2014-01-07       Impact factor: 5.157

7.  Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy.

Authors:  Junichiro Nakata; Yusuke Suzuki; Hitoshi Suzuki; Daisuke Sato; Tatsuya Kano; Hiroyuki Yanagawa; Keiichi Matsuzaki; Satoshi Horikoshi; Jan Novak; Yasuhiko Tomino
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

8.  Association Between Tonsillectomy and Outcomes in Patients With Immunoglobulin A Nephropathy.

Authors:  Keita Hirano; Keiichi Matsuzaki; Takashi Yasuda; Masako Nishikawa; Yoshinari Yasuda; Kentaro Koike; Shoichi Maruyama; Takashi Yokoo; Seiichi Matsuo; Tetsuya Kawamura; Yusuke Suzuki
Journal:  JAMA Netw Open       Date:  2019-05-03

9.  Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.

Authors:  Yukihiro Wada; Kei Matsumoto; Taihei Suzuki; Tomohiro Saito; Nobuhiro Kanazawa; Shohei Tachibana; Ken Iseri; Motonori Sugiyama; Masayuki Iyoda; Takanori Shibata
Journal:  PLoS One       Date:  2018-11-02       Impact factor: 3.240

Review 10.  Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis.

Authors:  Hitoshi Suzuki
Journal:  Clin Exp Nephrol       Date:  2018-05-08       Impact factor: 2.801

View more
  3 in total

Review 1.  The Gut and Kidney Crosstalk in Immunoglobulin A Nephropathy.

Authors:  Luis Sanchez-Russo; Arun Rajasekaran; Sofia Bin; Jeremiah Faith; Paolo Cravedi
Journal:  Kidney360       Date:  2022-06-27

2.  Associations of left renal vein entrapment with IgA nephropathy and Henoch-Schönlein purpura nephritis.

Authors:  Fengmei Wang; Huizi Zhu; Shougang Bao; Hengtao Qi; Liang Xu; Xiang Liu; Chunjuan Zhai; Xiaowei Yang; Rong Wang
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

3.  Serum Levels of miR-148b and Let-7b at Diagnosis May Have Important Impact in the Response to Treatment and Long-Term Outcome in IgA Nephropathy.

Authors:  Nikoleta M Kouri; Maria Stangou; George Lioulios; Zoi Mitsoglou; Grazia Serino; Samantha Chiurlia; Sharon Natasha Cox; Persia Stropou; Francesco P Schena; Aikaterini Papagianni
Journal:  J Clin Med       Date:  2021-05-05       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.